Afolayan A O, Adebusoye L A, Cadmus E O, Ayeni F A
Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria.
Chief Tony Anenih Geriatric Centre, University College Hospital, Ibadan, Oyo State, Nigeria.
Heliyon. 2020 May 29;6(5):e03971. doi: 10.1016/j.heliyon.2020.e03971. eCollection 2020 May.
Type 2 diabetes (T2D) is a prevalent non-communicable disease among the world's growing elderly population. The contribution of the gut microbiota to T2D in several Westernized countries has been established. However, there is little information on the role of the gut microbiota in T2D from the African continent where lifestyle and life expectancy are different.
This study sought to investigate gut microbiota variation in relation to elderly people living with T2D. in Nigeria.
Whole microbial community DNA were derived from the stool samples of healthy urban-dwelling elderly individuals and urban-dwelling elderly individuals with T2D. The V4 region of the 16S rRNA gene was Illumina-sequenced and analyzed using QIIME2.
Beta taxonomic diversity was significantly different between healthy elderly individuals and elderly individuals with T2D. However, no difference in the alpha taxonomic diversity and predicted functional alpha diversity of the gut microbiota was observed. The genus (T2D versus Healthy: 2.89% vs 2.21%), families (, T2D versus Healthy: 2.62 % vs 1.25%) and were enriched in elderly individuals with T2D, while members of (, Healthy versus T2D: 5.6% vs 3.2%) and (Healthy versus T2D: 3.45% vs 1.99%) were enriched in healthy volunteers. Pathways involved in amino acid biosynthesis were enriched in elderly individuals with T2D, while pathways involved in respiration and the biosynthesis of vital building blocks were enriched in healthy volunteers.
The study demonstrated for the first time in an African elderly population that the abundance of , , and within the gut varies in relation to T2D. Findings from this study suggest that the restoration of features associated with healthiness via the way of gut microbiota modification could be one step needed to improve elderly patient care.
2型糖尿病(T2D)是全球老年人口中普遍存在的非传染性疾病。肠道微生物群在几个西方国家对T2D的影响已得到证实。然而,在生活方式和预期寿命不同的非洲大陆,关于肠道微生物群在T2D中的作用的信息却很少。
本研究旨在调查尼日利亚患有T2D的老年人的肠道微生物群变化。
从健康的城市老年个体和患有T2D的城市老年个体的粪便样本中提取全微生物群落DNA。对16S rRNA基因的V4区域进行Illumina测序,并使用QIIME2进行分析。
健康老年人和患有T2D的老年人之间的β分类多样性存在显著差异。然而,未观察到肠道微生物群的α分类多样性和预测功能α多样性存在差异。在患有T2D的老年人中,属(T2D与健康:2.89%对2.21%)、科(,T2D与健康:2.62%对1.25%)和属富集,而在健康志愿者中,属(,健康与T2D:5.6%对3.2%)和属(健康与T2D:3.45%对1.99%)的成员富集。参与氨基酸生物合成的途径在患有T2D的老年人中富集,而参与呼吸和重要构件生物合成的途径在健康志愿者中富集。
该研究首次在非洲老年人群中证明,肠道内、和的丰度与T2D有关。本研究结果表明,通过改变肠道微生物群来恢复与健康相关的特征可能是改善老年患者护理所需的一步。